Q&A: A New Test For Drug-Resistant HIV Breaks All the Scientific Rules
Aldatu Selected for AdvaMed 2015 Innovation Showcase
Washington, DC, 18th September 2015 (download press release .pdf) AdvaMed 2015: The MedTech Conference, the leading gathering of medical technology professionals in North America, has awarded 48 scholarships to early and …
Aldatu Named a 2015 RESI Innovator
Aldatu was selected to participate in the Innovation Challenge as part of the Redefining Early State Investments (RESI) Conference being held in Boston on September 16th, 2015. Aldatu will join 29 other innovative life science companies in therapeutics, diagnostics, medical devices, and healthcare IT tracks in an exhibition-style presentation format throughout the day-long conference.
Aldatu Biosciences Receives $1.5 Million Direct-to-Phase II SBIR Grant from the NIAID for HIV Drug Resistance Diagnostic Development
Cambridge, MA, 12th March 2015 (download press release .pdf) Aldatu Biosciences, a novel diagnostics platform company focused on improving HIV patient care globally, today announced it has been awarded a Direct-to-Phase …
$250K Verizon Prize is a “Game-Changer” for Aldatu
A $250,000 prize to Aldatu Biosciences announced today from the Verizon Powerful Answers Awards stands to fundamentally change the way HIV treatment is delivered across the world by advancing the development of Aldatu’s affordable HIV drug resistance diagnostic, PANDAA™ HIV6.
Aldatu Biosciences Named a Verizon Powerful Answers Award Winner for 2014
Aldatu Biosciences is proud to announce it has been named a 2014 Powerful Answers Award winner in the Healthcare category. Aldatu is one of three winners in the Healthcare category and one of 12 winners total (three in each category). The ideas that win the top prizes of $1 million in each category will be revealed on Jan. 27, 2015 in New York City. The remaining eight winners will receive $250,000 each, for a total of $6 million awarded by Verizon.
Aldatu’s HIV drug resistance technology featured in the Boston Herald
[gview file=”https://s3.amazonaws.com/Aldatu_Content/Boston+Globe+Article.pdf” height=”724px” save=”1″] More information: Startup Tests Resistance to HIV Drugs – Boston Herald
Aldatu selected for 2014 MassChallenge Accelerator
On May 21st, MassChallenge announced the 2014 class of companies that will participate in the world’s largest accelerator program for early-stage startups – and Aldatu is on the list. As …
Aldatu Takes the Grand Prize at the Harvard Deans’ Health & Life Sciences Challenge
On May 19th, the Harvard Innovation Lab hosted their Demo Day as the concluding event of the 2014 Deans’ Health & Life Sciences Challenge, where Aldatu Biosciences was named the winner of the Bertarelli Foundation Grand Prize.